Inhibition of potassium dichromate mutagenicity by todralazine

Mutagenesis

Volumn 12, Issue 6, 1997, Pages 411-415

  Gasiorowski, Kazimierz ^a   Szyba, Katarzyna ^a   Wozniak, Dorota ^a   Gulanowski, Bogdan ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CHROMIUM; DICHROMATE POTASSIUM; TODRALAZINE;

AMES TEST; ARTICLE; BACILLUS SUBTILIS; CARCINOGENIC ACTIVITY; CARCINOGENICITY; CELL MEMBRANE TRANSPORT; CONTROLLED STUDY; GENOTOXICITY; MUTAGENIC ACTIVITY; MUTAGENICITY; NONHUMAN; PRIORITY JOURNAL; SPECTROPHOTOMETRY;

BACILLUS SUBTILIS; BACTERIA (MICROORGANISMS);

EID: 0030819232     PISSN: 02678357     EISSN: None     Source Type: Journal    
DOI: 10.1093/mutage/12.6.411     Document Type: Article

References (43)

1. Bagchi,D., Hassoun,E.A., Bagchi,M., Muldoon,D.F. and Stohs,S.J. (1995) Oxidative stress induced by chronic administration of sodium dichromate [Cr(VI)] to rats. Comp. Biochem. Physiol., 110C, 281-287.
2. Baker,R.S.U., Bonin,A.M., Arlanskas,A., Tandon,R.K., Crisp,P.T. and Ellis,J. (1984) Chromium(VI) and apparent phenotypic reversion in Salmonella TA100. Mutat. Res., 138, 127-132.
3. Bourke,G.J., Daly,L.E. and McGilvray,J. (1985) Regression and correlation. In Bourke,G.J. (ed.), Interpretation and Uses of Medical Statistics. Blackwell Scientific Publishers, Oxford, UK, pp. 131-158.
4. Chlopkiewicz,B., Ejchart,A. and Marczewska,J. (1995a) Studies on the mechanism of mutagenicity and genotoxicity induced by dihydralazine. Acta Biochim. Pol., 42, 291-296.
5. Chlopkiewicz,B., Ejchart,A. and Marczewska,J. (1995b) Genetic effects of binazine (todralazine) and hydaralazine in vitro and in vivo. Acta Pol. Pharmacol. Drug Res., 52, 31-33.
6. Cieslak-Golonka,M. (1995) Toxic and mutagenic effects of chromium (VI). A review. Polyhedron, 15, 3667-3689.
7. Cohen,M.D., Kargacin,B., Klein,C.B. and Costa,M. (1993) Mechanisms of chromium carcinogenicity and toxicity. Crit. Rev. Toxicol., 23, 255-281.
8. Costa,M., Kraker,A.J. and Patierno,S.R. (1984) Toxicity and carcinogenicity of essential and non-essential metals. Chromium. In Costa,M. (ed.), Progress in Clinical Biochemistry. Springer-Verlag, Berlin, Germany, Vol. 1, pp. 13-16.
9. Danielsson,B.R.G., Hassoun,E. and Dencher,L. (1982) Embryo toxicity of chromium: distribution in pregnant mice and effect in embryonic cells in vitro. Arch. Toxicol., 51, 233-245.
10. De Flora,S. and Wetterhahn,K.E. (1989) Mechanisms of chromium metabolism and genotoxicity. Life. Chem. Rep., 7, 169-244.
11. De Flora,S., Zanacchi,P., Bennicelli,C., Comoirano,A., Cavanna,M., Sciba,L., Cajelli,E., Faggin,P. and Brambilla,G. (1982) In vivo and in vitro genotoxicity of three antihypertensive hydrazine derivatives (hydralazine, dihydralazine and endralazine). Environ. Mutagen., 4, 605-619.
12. De Flora,S., Bagnasco,M., Serra,D. and Zanacchi,P. (1990) Genotoxicity of chromium compounds, a review. Mutat. Res., 238, 99-172.
13. Feig,D.L., Reid,T.M. and Loeb,L.A. (1994) Reactive oxygen species in tumorigenesis. Cancer. Res., 54 (suppl.), 1890s-1894s.
14. Gasiorowski,K., Szyba,K., Sawicka,J. and Gulanowski,B. (1993) Mutagenicity of B(a)P in the presence of some hydralazine derivatives. Pol. J. Occup. Med. Environ. Hlth, 6, 383-389.
15. Gasiorowski,K., Szyba,K. and Urban,J. (1994a) Todralazine influence upon the mutagenicity of some direct- and indirect-acting mutagens. Mutat. Res., 324, 133-137.
16. Gasiorowski,K.,Gulanowski,B., Szyba,K. and Urban,J. (1994b) Study of the mechanisms of todralazine antimutagenic activity: the effect upon mutagenicity of daunorubicin. Int. J. Occup. Med. Environ. Hlth, 7, 371-378.
17. Gasiorowski,K., Szyba,K., Sawicka,J. and Gulanowski,B. (1995) Evaluation of the mechanisms of todralazine effect on mutagenicity of benzo(a)pyrene. Int. J. Occup. Med. Environ. Hlth, 8, 267-273.
18. Gasiorowski,K., Brokos,B. and Kolaczynska,B. (1997) Antimutagenic activity of todralazine in human blood cell cultures. Anticancer. Res., submitted.
19. Gulanowski,B., Cieslak-Golonka,M., Szyba,K. and Urban,J. (1994) In vitro studies on the DNA impairments induced by Cr(III) complexes with cellular reductants. BioMetals, 7, 177-184.
20. Hartwig,A. (1995) Current aspects in metal genotoxicity. Mini-review. BioMetals, 8, 3-11.
21. IARC (1990) Monographs on the Evaluation of the Carcinogenic Risks to Humans, Vol. 49: Chromium, Nickel and Welding. International Agency for Research on Cancer, Lyon, France.
22. Kada,T., Sadaie,Y. and Sakamoto,Y. (1984) Bacillus subtilis repair test. In Kilbey,B.J., Legator,M., Nicols,W. and Ramel,C. (eds), Handbook of Mutagenicity Test Procedures. Elsevier, Amsterdam, The Netherlands, pp. 13-31.
23. Kadiiska,M.B., Xiang,Q.-H. and Mason,R.P. (1994) In vivo free radical generation by chromium(VI): an electron spin-trapping investigation. Chem. Res. Toxicol., 7, 800-805.
24. Kuroda,K., Endo,G., Okamoto,A., Yoo,Y.S. and Hariguchi,S.-i. (1991) Genotoxicity of berylium, gallium and antimony in short-term assays. Mutat. Res., 264, 163-170.
25. Langerwerf,J.S.A., Bakkeren,H.A. and Jongen,W.M.T. (1985) A comparison of the mutagenicity of soluble trivalent chromium compounds with that of potassium chromate. Ecotoxicol. Environ. Safety, 9, 92-100.
26. Lever,A.B.P. (1984) Chromium III d3. In Lever,A.B.P. (ed.), Inorganic Electronic Spectroscopy, 2nd Edn. Elsevier, Amsterdam, The Netherlands, pp. 417-429.
27. Maron,D.M. and Ames,B.N. (1983) Revised method for the Salmonella mutagenicity test. Mutat. Res., 113, 173-215.
28. Nikaido,H. and Vaara,M. (1985) Molecular basis of bacterial outermembrane permeability. Microbiol. Rev., 49, 1-32.
29. Nishioka,H. (1975) Mutagenic activities of metal compounds in bacteria. Mutat. Res., 31,185-189.
30. Paustenbach,D.J., Finley,B.L. and Kacew,S. (1996) Biological relevance and consequences of chemical- or metal-induced DNA cross-linking. Proc. Soc. Exp. Biol. Med., 211, 211-217.
31. Petrilli,F.L. and De Flora,S. (1977) Toxicity and mutagenicity of hexavalent chromium on Salmonella typhimurium. Appl. Environ. Microbiol., 33, 805-809.
32. Shi,X. and Dalal,N.S. (1992) The role of Superoxide radical in chromium(VI)-generated hydroxyl radicals. The Cr(VI) Haber-Weiss cycle. Arch. Biochem. Biophys., 292, 323-327.
33. Shi,X., Dalal,N.S. and Kasprzak,K.S. (1993) Generation of free radicals from hydrogen peroxide and lipid hydroperoxides in the presence of Cr(III). Arch. Biochem. Biophys., 302, 294-299.
34. Snow,E.T. (1992) Metal carcinogenesis: mechanistic implications. Pharmacol. Ther., 53, 31-65.
35. Standeven,A.M. and Wetterhahn,K.E. (1989) Chromium(VI) toxicity: uptake, reduction, DNA damage. J. Am. Cell Toxicol., 8, 1275-1283.
36. Sugden,K.D. and Wetterhahn,K.E. (1996) EPR evidence for chromium(V) binding to phosphate and pyrophosphate: implications for chromium(V)-DNA interactions. Inorg. Chem., 35, 3727-3728.
37. Sugden,K.D., Geer,R.D. and Rogers,S.J. (1994) Oxygen radical-mediated DNA damage by redox-active Cr(III) complexes. Biochemistry, 31, 11626-11631.
38. Szyba,K., Cieslak-Golonka,M., Gasiorowski,K. and Urban,J. (1992) Mutagenic activity of copper(II) chromate and dichromate complexes with polypiridines. BioMetals, 5, 157-161.
39. Von Burg,R. and Liu,D. (1993) Chromium and hexavalent chromium. J. Appl. Toxicoi., 13, 225-230.
40. Wetterhahn,K.E. and Dudek,E.J. (1996) Environmental metal carcinogens: genotoxicity and altered gene expression by direct metal-mediated and indirect oxidative pathways. New J. Chem., 20, 199-203.
41. Wetterhahn,K.E. and Hamilton,J.W. (1989) Molecular basis of hexavalent chromium carcinogenicity: effect of gene expression. Sci. Total. Environ., 86, 113-129.
42. Williams,G. M., Mazue,G., McQueen,C. A. and Shimada.T. (1980) Genotoxicity of the antihypertensive drugs hydralazine and dihydralazine. Science, 210, 329-330.
43. Zakour,R. A. and Glickman,B. W. (1984) Metal-induced mutagenesis in the lacI gene of Escherichia coli. Mutat. Res., 126, 9-18.